http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0711119-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70b4adcb246898471965051b9ea8b3b1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74
filingDate 2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7af0674e79a453b2c7e1959e0050b2
publicationDate 2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0711119-A2
titleOfInvention microbial administration of obesity-associated intestinal peptides
abstract MICROBIAN ADMINISTRATION OF INTESTINAL OBESITY ASSOCIATED PEPTIDES. The present invention relates to the microbial administration of obesity-associated peptides. More specifically the invention relates to the use of genetically modified yeast and / or lactic acid bacteria for the administration of neuropeptides and / or peptide hormones that act to stimulate or inhibit food intake and / or energy homeostasis.
priorityDate 2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612

Total number of triples: 22.